Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Breast 3Classical hematology 2Thoracic 1

Conditions

Febrile Neutropenia 2

Interventions

Rivaroxaban 8Surveys and Questionnaires 7Heparin, Low-Molecular-Weight 5apixaban 4fludarabine 3Blood Specimen Collection 3pegfilgrastim 2epoetin beta 2Therapeutics 2Polymerase Chain Reaction 2Piperacillin, Tazobactam Drug Combination 2Observation 2Microarray Analysis 2Melphalan 2Influenza Vaccines 2Immunoenzyme Techniques 2Flow Cytometry 2Epoetin Alfa 2Data Collection 2Dabigatran 2Biopsy 2ziprasidone 1ribociclib 1ravulizumab 1palbociclib 1oprelvekin 1iron isomaltoside 1000 1fludarabine phosphate 1edoxaban 1calcium heparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × pegfilgrastim × Classical hematology × Clear all
NCT04662892 2020-12-23

POEM

Coherus Oncology, Inc.

Unknown
200 enrolled
Classical hematology

Febrile Neutropenia

NCT04460079 2020-07-07

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Cinnagen

Completed
654 enrolled
Classical hematology

Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡